onr:"swepub:oai:prod.swepub.kib.ki.se:143002588"
Search: onr:"swepub:oai:prod.swepub.kib.ki.se:143002588" > Efficacy and Safety...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Mnkugwe, RHKarolinska Institutet (author)
Efficacy and Safety of Praziquantel for Treatment of Schistosoma mansoni Infection among School Children in Tanzania
- Article/chapterEnglish2020
Publisher, publication year, extent ...
- 2019-12-27
- MDPI AG,2020
Numbers
- LIBRIS-ID:oai:prod.swepub.kib.ki.se:143002588
- http://kipublications.ki.se/Default.aspx?queryparsed=id:143002588URI
- https://doi.org/10.3390/pathogens9010028DOI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- Single-dose targeted praziquantel preventive chemotherapy is the WHO-recommended intervention for schistosomiasis control in endemic countries. The objective of this study was to assess the efficacy and safety of single-dose praziquantel among Schistosoma mansoni-infected children in north-western Tanzania. A prospective safety and efficacy surveillance study was conducted among 341 school-going children treated with a single-dose praziquantel 40 mg/kg body weight. Socio-demographic, pre-treatment, and post-treatment stool examination and safety data were collected. The primary and secondary outcomes were treatment efficacy (parasitological cure and egg reduction rates at three weeks post-treatment) and treatment-related adverse events, respectively. The overall cure rate and egg reduction rate were 81.2% (76.8–85.3%) and 95.0% (92.7–97.3%), respectively. There was no significant association between cure rate and pre-treatment infection intensity. The incidence of treatment-associated adverse events was 28.5% (23.7–33.3%), with abdominal pain being the most common. Post-treatment abdominal pain and vomiting were significantly associated with pre-treatment infection intensity (p < 0.001) and anemia (p = 0.03), respectively. Praziquantel single-dose is still safe and efficacious against Schistosoma mansoni infection. However, the lack of cure in about one-fifth and adverse events in a quarter, of the infected children indicate the need for close praziquantel safety monitoring and treatment optimization research to improve efficacy.
Added entries (persons, corporate bodies, meetings, titles ...)
- Minzi, OS (author)
- Kinung'hi, SM (author)
- Kamuhabwa, AA (author)
- Aklillu, EKarolinska Institutet (author)
- Karolinska Institutet (creator_code:org_t)
Related titles
- In:Pathogens (Basel, Switzerland): MDPI AG9:12076-0817
Internet link
Find in a library
- Pathogens (Basel, Switzerland) (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Mnkugwe, RH
- Minzi, OS
- Kinung'hi, SM
- Kamuhabwa, AA
- Aklillu, E
- Articles in the publication
- Pathogens (Basel ...
- By the university
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
